Clinical Trial Update: Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-ALL [EARLY_Phase 1]

View source ↗

Summary

The entry reports an early-phase 1 clinical trial evaluating CD5-targeted CAR-T cells for relapsed/refractory CD5-positive T-cell acute lymphoblastic leukemia, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• CD5 CAR-T cells (CD5-targeted chimeric antigen receptor T cells)

Snippet

Sponsor: Zhejiang University | Conditions: T-Acute Lymphoblastic Leukemia | EARLY_Phase 1 | Status: RECRUITING